BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38220587)

  • 21. Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.
    Galanaud JP; Sevestre MA; Pernod G; Kahn SR; Genty C; Terrisse H; Brisot D; Gillet JL; Quéré I; Bosson JL
    J Thromb Haemost; 2017 Jun; 15(6):1123-1131. PubMed ID: 28317330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
    Bikdeli B; Caraballo C; Trujillo-Santos J; Galanaud JP; di Micco P; Rosa V; Cusidó GV; Schellong S; Mellado M; Del Valle Morales M; Gavín-Sebastián O; Mazzolai L; Krumholz HM; Monreal M;
    JAMA Cardiol; 2022 Aug; 7(8):857-865. PubMed ID: 35830171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study.
    Blondon M; Jimenez D; Robert-Ebadi H; Del Toro J; Lopez-Jimenez L; Falga C; Skride A; Font L; Vazquez FJ; Bounameaux H; Monreal M;
    J Thromb Haemost; 2021 Feb; 19(2):408-416. PubMed ID: 33119949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
    Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
    Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
    Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
    Riera-Mestre A; Mora-Luján JM; Trujillo-Santos J; Del Toro J; Nieto JA; Pedrajas JM; López-Reyes R; Soler S; Ballaz A; Cerdà P; Monreal M;
    Orphanet J Rare Dis; 2019 Aug; 14(1):196. PubMed ID: 31399146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
    Goto S; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Weitz JI; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat A; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    JAMA Netw Open; 2020 Oct; 3(10):e2022886. PubMed ID: 33112399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
    Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
    Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
    Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
    Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial Ischemic Events Are a Major Complication in Cancer Patients with Venous Thromboembolism.
    Brenner B; Bikdeli B; Tzoran I; Madridano O; López-Reyes R; Suriñach JM; Blanco-Molina Á; Tufano A; Núñez JJL; Trujillo-Santos J; Monreal M;
    Am J Med; 2018 Sep; 131(9):1095-1103. PubMed ID: 29807000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
    Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
    Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban for the treatment of venous thromboembolism. The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Kucher N; Aujesky D; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Spirk D
    Thromb Haemost; 2016 Aug; 116(3):472-9. PubMed ID: 27346301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
    Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
    Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prior thromboprophylaxis and outcome in patients experiencing acute venous thromboembolism after an acute medical illness.
    Merah A; Bertoletti L; Ginzarly M; Zeltser D; Barrón M; Cañas I; Villalta J; Bucherini E; Monreal M;
    Eur J Intern Med; 2016 May; 30():72-76. PubMed ID: 26975476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in neurosurgical patients who develop venous thromboembolism: a review of the RIETE registry.
    Cote LP; Greenberg S; Caprini JA; Stone J; Arcelus JI; López-Jiménez L; Rosa V; Schellong S; Monreal M;
    Clin Appl Thromb Hemost; 2014 Nov; 20(8):772-8. PubMed ID: 24798686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.